Show simple item record

dc.contributor.authorGarcía, Elisa
dc.contributor.authorCoa, Juan C.
dc.contributor.authorOtero, Elver
dc.contributor.authorCarda, Miguel
dc.contributor.authorVélez, Iván D.
dc.contributor.authorRobledo, Sara M.
dc.contributor.authorCardona G, Wilson I
dc.date.accessioned2018-05-21T10:26:12Z
dc.date.available2018-05-21T10:26:12Z
dc.date.issued2018
dc.identifier.citationGarcía, E., Coa, J.C., Otero, E. et al. Med Chem Res (2018) 27: 497. https://doi.org/10.1007/s00044-017-2076-6ca_CA
dc.identifier.issn1054-2523
dc.identifier.issn1554-8120
dc.identifier.urihttp://hdl.handle.net/10234/174759
dc.description.abstractWe report herein the synthesis and biological activities (cytotoxicity, leishmanicidal, and trypanocidal) of several furanchalcone–quinoline, furanchalcone–chromone, and furanchalcone–imidazole hybrids. The synthesized compounds were evaluated against amastigotes forms of L. (V) panamensis, which is the most prevalent Leishmania species in Colombia and against Trypanosoma cruzi, which is the major pathogenic species to humans. Cytotoxicity was evaluated against human U-937 macrophages. Compounds (6e, 8a–8f, 11b, and 11c) were active against both L. (V) panamensis and T. cruzi being 8e and 8f the most active compounds with an EC50 of 0.78 and 2.16 µM against L. (V) panamensis, respectively, and 0.66 and 0.72 µM against T. cruzi, respectively. Seven hybrid compounds showed better activity than meglumine antimoniate and the anti-trypanosomal activity of nine compounds were higher than benznidazole. Although these compounds showed toxicity for mammalian U-937 cells, they still have the potential to be considered as candidates for antileishmanial or trypanocydal drug development. There is not a clear relationship between the antiprotozoal activity and the length of the alkyl linker. However, we obtained higher bioactivity when the alkyl linker has nine and twelve carbon atoms. Furanchalcone-imidazole hybrids were the most active of all compounds, showing that the imidazole salt moiety is important for their biological actions.ca_CA
dc.format.extent15 p.ca_CA
dc.language.isoengca_CA
dc.publisherSpringer Verlagca_CA
dc.relation.isPartOfMed Chem Res (2018) 27ca_CA
dc.subjectLeishmaniasisca_CA
dc.subjectChagas diseaseca_CA
dc.subjectAntiprotozoal activityca_CA
dc.subjectFuranchalconeca_CA
dc.subjectHybridsca_CA
dc.subjectQuinolineca_CA
dc.titleSynthesis and antiprotozoal activity of furanchalcone–quinoline, furanchalcone–chromone and furanchalcone–imidazole hybridsca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1007/s00044-017-2076-6
dc.relation.projectIDgrant CODI 6203 and CIDEPROca_CA
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_CA
dc.relation.publisherVersionhttps://link.springer.com/article/10.1007/s00044-017-2076-6ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record